Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myoinositol is a naturally occurring cyclic carbohydrate crucial for cell signaling, lipid metabolism, and insulin sensitivity. It serves as a precursor for phosphatidylinositol and phosphoinositides. While not a direct drug target, it is supplemented to address conditions like PCOS, metabolic syndrome, and insulin resistance. It plays a role in FSH signaling and potentially mood regulation.
Myoinositol itself is not directly targeted by drugs. It acts as a supplement to influence metabolic and signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myoinositol.